Amorphous paroxetine composition
US6503927B1 · kind B1 · utility
6Cited by
9References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1999 |
| Grant date | Jan 7, 2003 |
| Priority date | — |
| Expiry date | Oct 28, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable amorphous paroxetine hydrochloride composition suitable as a therapeutic agent is prepared employing an aqueous solvent medium containing an acidulant and polyvinylpyrrolidone and drying the resulting solid dispersion. The preferred compositions include amorphous paroxetine hydrochloride, polyvinylpyrrolidone and citric acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.